N/A N=25 Treatment

An Evaluation of the Effect of the Erchonia Corporation Violet Zerona® Z6 for Body Contouring

Circumference Reduction

Bottom Line

View on ClinicalTrials.gov: NCT05674292 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Sep 2023

Primary outcome: Primary: Combined Circumference Reduction in Inches of the Waist, Hips, and Bilateral Thighs — -3.91 inches

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: Erchonia Violet Zerona Z6 (Device)
Age: Adult, Older Adult · 18+ yrs
Sex: All
Sponsor: Erchonia Corporation
Primary completion: Mar 2023

Outcome Measures

Outcome	Result	p-value
PRIMARY Combined Circumference Reduction in Inches of the Waist, Hips, and Bilateral Thighs	-3.91	—

Summary

The purpose of this clinical study is to determine the effectiveness of the Erchonia® Violet Zerona Z6 (manufactured by Erchonia Corporation (the Company), an over-the-counter (OTC) laser device, in providing noninvasive body circumference reduction.

Eligibility Criteria

Inclusion Criteria

BMI is 30 or less
18 years of age or older

Exclusion Criteria

Pregnant
Open wounds (sores, cuts, ulcers, etc.)
Individuals with or being treated for any cancerous growth

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT05674292). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.